Pituitary in the Spotlight

Abstract

The German Society of Endocrinology (DGE) has a long-standing scientific and clinical focus on the pituitary. The pituitary working group ‘Arbeitsgemeinschaft Hypophyse’ is an interdisciplinary special interest group with a focus on advancing diagnosis and treatment of pituitary conditions. On the occasion of the English publication of the S2K clinical guideline Diagnosis and therapy of clinically hormonally inactive pituitary tumors, we present here a series of 12 articles from internationally renowned authors from inside and outside of Germany.

Key words

pituitary - adenoma - tumor - neuroendocrine - carcinoma - classification

Publication History

Received: 20 January 2021
Received: 20 January 2021

Accepted: 21 January 2021

Article published online:
09 March 2021

• References

• 1 https://www.awmf.org/leitlinien/detail/ll/089-002.html
• 2 Osamura RY, Grossman A, Korbonits M. et al. WHO Classification of Tumours of Endocrine Organs. WHO; Lyon, France: 2017. Pituitary adenoma. 14-18 Chapter 1: Tumors of the Pituitary Gland.
• 3 McCormack A, Dekkers OM, Petersenn S. et al. ESE survey collaborators. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol 2018; 178: 265-276
• 4 Trouillas J, Burman P, McCormack A. et al. Aggressive pituitary tumours and carcinomas: Two sides of the same coin?. Eur J Endocrinol 2018; 178: C7-C9
• 5 Asa SL, Casar-Borota O, Chanson P. et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): An International Pituitary Pathology Club proposal. Endocr Relat Cancer 2017; 24: C5-C8
• 6 Ho KKY, Fleseriu M, Wass J. et al. A tale of pituitary adenomas: To NET or not to NET : Pituitary Society position statement. Pituitary 2019; 22: 569-573
• 7 Trouillas J, Jaffrain-Rea ML, Vasiljevic A. et al. How to classify the Pituitary Neuroendocrine Tumors (PitNET)s in 2020. Cancers (Basel) 2020; 12: 514
• 8 Rindi G, Klimstra DS, Abedi-Ardekani B. et al. A common classification framework for neuroendocrine neoplasms: An International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018; 31: 1770-1786
• 9 Villa C, Vasiljevic A, Jaffrain-Rea ML. et al. A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): A European Pituitary Pathology Group (EPPG) proposal. Virchows Arch 2019; 475: 687-692. DOI: 10.1007/s00428-019-02655-0.. Epub 2019 Oct 2.Virchows Arch. 2019. PMID: 31578606 Review.
• 10 Ho KKY, Fleseriu M, Kaiser U. J Endocrine Society 2021; accepted for publication
• 11 Neou M, Villa C, Armignacco R, Jouinot A. et al. Cancer Cell 2020; 37: 123-134.e5. DOI: 10.1016/j.ccell.2019.11.002.. Epub 2019 Dec 26. PMID: 31883967
• 12 Saeger et al. ECED-10-2020-0449-Endocrinology-R.R. 1 [Pituitary]
• 13 Hondronikos N, Alomari A, Schrader M. et al. Rhinological Consequences of Microsurgical Endonasal-Transsphenoidal Surgery for Pituitary Tumors. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1155-6269. Online ahead of print
• 14 Giese S, Nasi-Kordhishti I, Honegger J. Outcomes of Transsphenoidal Microsurgery for Prolactinomas - A Contemporary Series of 162 Cases. Exp Clin Endocrinol Diabetes 2021; DOI: 10.1055/a-1247-4908..
• 15 Mende KC, Pantel TF, Flitsch J. et al. Revived Attention for Adult Craniopharyngioma. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1217-7282.. Online ahead of print.
• 16 Osterhage K, Rotermund R, Droste M. et al. Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 Patients. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1260-3975..
• 17 Petersenn S. Medical therapy of aggressive pituitary tumors, ECED accepted
• 18 Ntali G, Hakami O, Wattegama M. et al. Mortality of Patients with Cushing’s Disease. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1197-6380.. Online ahead of print
• 19 Albani A, Theodoropoulou M. Persistent Cushing's Disease after Transsphenoidal Surgery: Challenges and Solutions. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1220-6056.. Online ahead of print
• 20 Quinkler M, Petroff D, Knappe UJ. et al. Medical Therapy of Acromegaly in Germany 2019 - Data from the German Acromegaly Registry. Exp Clin Endocrinol Diabetes 2020; 30. DOI: 10.1055/a-1191-2437.. Online ahead of print
• 21 Störmann S, Schopohl J, Bullmann C. et al. Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1247-4713.. Online ahead of print
• 22 Amereller F, Küppers AM, Schilbach K. et al. Clinical Characteristics of Primary Hypophysitis - A Single-Centre Series of 60 Cases. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1163-7304.. Online ahead of print
• 23 Kienitz T, Hahner S, Burger-Stritt S. et al. Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions. Exp Clin Endocrinol Diabetes 2020; DOI: 10.1055/a-1217-7208.. Online ahead of print